A Comprehensive Analysis of CNOT4: A Potential Drug Target and Biomarker

Target Name: CNOT4

NCBI ID: G4850

CNOT4

A Comprehensive Analysis of CNOT4: A Potential Drug Target and Biomarker

Abstract:

CNOT4, or colchicine N-O-acetyltransferase 4, is a gene that encodes a protein involved in the development and maintenance of neural stem cells. The study of CNOT4 has generated significant interest due to its potential implications as a drug target and biomarker. This article will provide an overview of CNOT4, its function, and its potential as a drug target and biomarker.

Introduction:

CNS neural stem cells are a vital cell type that play a critical role in the development and maintenance of the nervous system. These stem cells have the ability to generate new neurons and tissues, and they can be influenced by various factors, including Wnt signaling. CNOT4 is a gene that encodes a protein involved in the development and maintenance of neural stem cells.

Functional Analysis of CNOT4:

CNOT4 is a 23-kDa protein that is expressed in various tissues, including brain, spinal cord, and muscle. It is involved in the N-O-acetyl transferase (NOT) family, which is a well-established gene family involved in the transfer of acetyl groups to various proteins. CNOT4 is responsible for the transfer of acetyl groups to the L-shape protein p120, which is critical for the stability and survival of neural stem cells.

Preclinical Studies of CNOT4:

Preclinical studies have demonstrated that CNOT4 plays a crucial role in the development and maintenance of neural stem cells. Experiments have shown that inhibition of CNOT4 reduces the number of neural stem cells, while activation of CNOT4 increases the number of neural stem cells. Additionally, these studies have shown that CNOT4 is involved in the regulation of stem cell proliferation and survival.

Drug Target Potential of CNOT4:

The drug target potential of CNOT4 is high due to its involvement in the development and maintenance of neural stem cells. As a result, CNOT4 has been identified as a potential drug target for various neurological disorders, including neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Biomarker Potential of CNOT4:

CNOT4 has also been identified as a potential biomarker for various neurological disorders. The regulation of CNOT4 expression and activity has been shown to be involved in various neurological disorders, including neurodegenerative diseases. Therefore, CNOT4 has the potential to serve as a biomarker for these disorders.

Conclusion:

In conclusion, CNOT4 is a gene that encodes a protein involved in the development and maintenance of neural stem cells. Its involvement in the N-O-acetyl transferase family makes it a potential drug target for various neurological disorders. Additionally, its potential as a biomarker for neurodegenerative diseases makes it an attractive target for researchers. Further studies are needed to fully understand the role of CNOT4 in neural stem cell development and its potential as a drug target and biomarker.

Protein Name: CCR4-NOT Transcription Complex Subunit 4

Functions: Has E3 ubiquitin ligase activity, promoting ubiquitination and degradation of target proteins (PubMed:11823428, PubMed:22159038, PubMed:26575292). Involved in activation of the JAK/STAT pathway (PubMed:11823428, PubMed:22159038). Catalyzes ubiquitination of methylated RBM15 (PubMed:26575292). Plays a role in quality control of translation of mitochondrial outer membrane-localized mRNA (PubMed:29861391). As part of the PINK1-regulated signaling, upon mitochondria damage, ubiquitinates ABCE1 and thereby recruits autophagy receptors to the mitochondrial outer membrane to initiate mitophagy (PubMed:29861391)

The "CNOT4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CNOT4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets